Physician profile
Tanner John Ferguson
NPI 1326545062
$49,234.54
in general payments reported to CMS, 2019-2025
16 companies · $46K in 2025
The $46K reported for 2025 was more than what 98% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.99 · 2021: $165 · 2022: $524 · 2023: $1,474 · 2024: $592 · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $44K · Food and Beverage: $2,803 · Travel and Lodging: $1,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $44,119.59 |
| Food and Beverage | $2,803.43 |
| Travel and Lodging | $1,522.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $33,909.91 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Glaukos Corporation | $6,787.91 | 2022-2025 | Travoprost Intraocular Implant - Idose, Istent Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Johnson & Johnson Surgical Vision, INC. | $5,430.60 | 2024-2025 | Healon Duet Pro, Compact Intuitiv, Tecnis Iol |
| Alcon Vision LLC | $1,924.99 | 2021-2025 | Lensx, Unity, Clareon |
| Sight Sciences, INC. | $261.61 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Dompe US, INC. | $190.08 | 2024-2025 | Oxervate |
| Abbvie INC. | $150.25 | 2023-2025 | |
| Allergan, INC. | $119.66 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $108.31 | 2024 | Rayone Emv, Rayone Aspheric, Omidria |
| Harrow Eye, LLC | $86.95 | 2023-2024 | |
| Bausch & Lomb Americas INC. | $81.16 | 2024-2025 | Xiidra |
| Oyster Point Pharma, INC. | $54.06 | 2023-2024 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $52.83 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $49.72 | 2023-2025 | |
| New World Medical,INC. | $26.50 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanner Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.